New drug for IBD, ulcerative colitis wins FDA approval
The FDA has approved Pfizer's etrasimod, branded as Velsipity, for treating adults with the inflammatory bowel disease (IBD) known as ulcerative colitis.
Source: nypost.com
Michael Chiorean News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Chiorean. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Chiorean Today - Breaking & Trending Today
U.S. FDA Approves Pfizer's VELSIPITY for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
13.10.2023 - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely ...
Source: wallstreet-online.de
FDA Approves Etrasimod for Moderately to Severely Active Ulcerative Colitis
The approval of oral, once-daily etrasimod 2 mg was based on positive data from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials.
Source: hcplive.com
FDA Approves New Drug for Ulcerative Colitis
Etrasimod is the second oral sphingosine-1-phosphate (S1P) receptor approved in the US for treating moderate to severe active ulcerative colitis in adults.
Source: medscape.com